Cymabay Therapeutics Inc Newark, CA - 94560

Cymabay Therapeutics Inc is categorized under Research and Development Laboratories in Newark, CA and active since 1991.

Cymabay Therapeutics Inc was established in 1991, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 541712 by the NAICS.

If you are seeking more information, feel free to contact Harold Van Wart at the company’s single location by writing to 3876 Bay Center Place, Newark, California CA 94560 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Cymabay Therapeutics Inc
Contact Person: Harold Van Wart
Address: 3876 Bay Center Place, Newark, California 94560
Website Address: metabolex.com
Annual Revenue (USD): $5.000.000 to $9.999.999
Founded: 1991
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Research and Development Laboratories
SIC Code: 8731
NAICS Code: 541712
Share This Business:

Cymabay Therapeutics Inc was started in 1991 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.

Feel free to contact Harold Van Wart for inquiries that concern Cymabay Therapeutics Inc by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the single location of Cymabay Therapeutics Inc can be found at the coordinates 37.627798,-122.126656 as well as the street address 3876 Bay Center Place in Newark, California 94560.

For its online presence, you may visit Cymabay Therapeutics Inc’s website at metabolex.com and engage with its social media outlets through on Twitter and on Facebook.